|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/82 | (2006.01) |
| C12Y 305/01001 | (2013.01) | ||
| C12N 9/82 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3642340 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18731853.0 |
| Europos patento paraiškos padavimo data | 2018-06-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/066647 |
| Data | 2018-06-21 |
| (87) | Numeris | WO 2018/234492 |
| Data | 2018-12-27 |
| (30) | Numeris | Data | Šalis |
| 17177237 | 2017-06-21 | EP | |
| 201762523061 P | 2017-06-21 | US | |
| 201715671086 | 2017-08-07 | US |
| (72) |
FRIEDRICH, Lars , DE
O'DONNELL, Anne , IE
|
| (73) |
Jazz Pharmaceuticals Ireland Limited ,
Fifth Floor, Waterloo Exchange Waterloo Road, 4 Dublin,
IE
|
| (54) | MODIFIED L-ASPARAGINASE |
| MODIFIED L-ASPARAGINASE |